Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BY 4.0Biomolecules

Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes

8 affiliations
  1. 1Institute of Biochemistry and Genetics, Ufa Federal Research Centre, Russian Academy of Sciences, 450054 Ufa, Russia
  2. 2Department of Medical Genetics and Fundamental Medicine, Faculty of General Medicine, Bashkir State Medical University, 450008 Ufa, Russia
  3. 3Department of Biology, Faculty of Stomatology, Bashkir State Medical University, 450008 Ufa, Russia
  4. 4Laboratory of Microfluidic Technology, Institute of Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia
  5. 5Laboratory of Cell Cultures, Institute of Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia
  6. 6Department of Endocrinology, Faculty of General Medicine, Bashkir State Medical University, 450008 Ufa, Russia
  7. 7Section of Statistical Multi-Omics, Department of Clinical & Experimental Medicine, School of Biosciences & Medicine, University of Surrey, Guildford GU2 7XH, UK
  8. 8Department of Psychology, Middlesex University, London NW4 4BT, UK

Abstract

MicroRNAs (miRNAs) are involved in the regulation of glucose metabolism and inflammatory processes associated with type 2 diabetes (T2D) and have potential as biomarkers and therapeutic targets. We analysed the expression of miR-155-5p, miR-141-3p, miR-15b-5p, miR-18a-5p, and miR-379-5p in peripheral blood mononuclear cells (PBMCs) from 79 patients with T2D and 88 non-diabetic controls. Differential expression analysis revealed significant downregulation of miR-15b-5p, miR-155-5p, and miR-18a-5p, and significant upregulation of miR-379-5p in T2D patients. Among the individual miRNAs, miR-15b-5p showed the highest ability to distinguish between T2D and controls (AUC = 0.82, 95% CI 0.76–0.89, p = 0.001). A model combining the four differentially expressed miRNAs (miR-155-5p, miR-15b-5p, miR-18a-5p, and miR-379-5p) with age, sex, and BMI had an AUC of 0.98, compared with 0.93 for age, sex, and BMI alone (p = 0.004, paired DeLong test); the optimism-corrected AUC was 0.97, although the bootstrap procedure did not account for optimism arising from miRNA selection. Functional enrichment analysis identified MAPK, Hippo, FoxO, insulin, AMPK and TGF-β signalling as consistently enriched across analyses based on experimentally supported and predicted miRNA targets.

Related

  1. Peripheral Blood Mononuclear Cell Expression Profile of Proliferation-, Ferroptosis-, and Immune-Related Targets in Breast Cancer.
    Rabia Demirtaş, Murat Kızılkaya, Eda Balkan +5
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textOncologyEurope PMC
  2. Cryopreserved Peripheral Blood Mononuclear Cells Recover Mitochondrial Function Following Overnight Culture Revealed by High-Resolution Respirometry
    R. 'Atiola, C. Puliuvea, N. Netzler +5
    medRxivPreprintCC BYFull textEndocrinology & metabolismmedRxiv
  3. Comparative Effects of Acrolein and Glyoxal on Redox Homeostasis, Antioxidant Defense and Membrane Properties in Human Peripheral Blood Mononuclear Cells: An In Vitro Study.
    Michal Kopera, Malgorzata Adamkiewicz, Joanna Bernasinska-Slomczewska +1
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Quantification of Y RNAs in peripheral blood mononuclear cells from patients with ankylosing spondylitis and healthy controls.
    Guilherme Castellani, Matheus Braga, Aléia Harumi Uchibaba Yamanaka +4
    Einstein (Sao Paulo, Brazil)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells
    Cees-Jan Oostwouder, Karin Vos, Mathijs R. Merkus +8
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
BibTeX
@article{timasheva2026expression,
  title = {{Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes}},
  author = {Yanina Timasheva and Olga Kochetova and Vitaly A. Markelov and Ksenia V. Danilko and Tatyana M. Kochetova and Diana Avzaletdinova and Gulnaz F. Korytina and Zhanna Balkhiyarova and Arie Nouwen},
  journal = {Biomolecules},
  year = {2026},
  month = oct,
  doi = {10.3390/biom16101503},
  url = {https://www.mdpi.com/2218-273X/16/10/1503},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Expression Analysis of microRNAs in Peripheral Blood Mononuclear Cells in Type 2 Diabetes
AU  - Yanina Timasheva
AU  - Olga Kochetova
AU  - Vitaly A. Markelov
AU  - Ksenia V. Danilko
AU  - Tatyana M. Kochetova
AU  - Diana Avzaletdinova
AU  - Gulnaz F. Korytina
AU  - Zhanna Balkhiyarova
AU  - Arie Nouwen
PY  - 2026
DA  - 2026/10/01
JO  - Biomolecules
DO  - 10.3390/biom16101503
UR  - https://www.mdpi.com/2218-273X/16/10/1503
AB  - MicroRNAs (miRNAs) are involved in the regulation of glucose metabolism and inflammatory processes associated with type 2 diabetes (T2D) and have potential as biomarkers and therapeutic targets. We analysed the expression of miR-155-5p, miR-141-3p, miR-15b-5p, miR-18a-5p, and miR-379-5p in peripheral blood mononuclear cells (PBMCs) from 79 patients with T2D and 88 non-diabetic controls. Differential expression analysis revealed significant downregulation of miR-15b-5p, miR-155-5p, and miR-18a-5p, and significant upregulation of miR-379-5p in T2D patients. Among the individual miRNAs, miR-15b-5p showed the highest ability to distinguish between T2D and controls (AUC = 0.82, 95% CI 0.76–0.89, p = 0.001). A model combining the four differentially expressed miRNAs (miR-155-5p, miR-15b-5p, miR-18a-5p, and miR-379-5p) with age, sex, and BMI had an AUC of 0.98, compared with 0.93 for age, sex, and BMI alone (p = 0.004, paired DeLong test); the optimism-corrected AUC was 0.97, although the bootstrap procedure did not account for optimism arising from miRNA selection. Functional enrichment analysis identified MAPK, Hippo, FoxO, insulin, AMPK and TGF-β signalling as consistently enriched across analyses based on experimentally supported and predicted miRNA targets.
SN  - 2218-273X
ER  -